TETadele Emagneneh

Tadele Emagneneh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tadele Emagneneh has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    5-year survival rate and determinants of decreased survival among patients with breast cancer in Africa: a systematic review and meta-analysis

    by Chalie Mulugeta, Tadele Emagneneh, Getinet Kumie, Assefa Sisay, Esuyawkal Mislu, Mulat Ayele, Aynalem Yetwale, Abebaw Alamrew

    Introduction: Breast cancer is the most commonly diagnosed cancer among women worldwide and a leading cause of cancer-related mortality. Survival varies across regions, with most deaths occurring in low- and middle-income countries due to limited early detection and treatment access. This study aimed to estimate the 5-year survival rate and identify determinants of decreased survival among patients with breast cancer in Africa. Methods: A systematic review of only retrospective cohort studies was conducted using PubMed, Hinari, EMBASE, Google Scholar, African Journals Online, African Index Medicus and Web of Science. The literature search was conducted for a 1-month duration (1–30 November 2024). We included all available articles without restriction on publication date to ensure a comprehensive review. Methodological quality was assessed using the Newcastle-Ottawa 2016 Critical Appraisal Checklist. Publication bias was evaluated using funnel plots and Egger’s test, and heterogeneity was assessed with the I 2 test. Data were analysed with Stata V.17. Results: 55 articles with 19 577 participants from 19 countries were included; 37 studies (4622 participants) were used to estimate pooled 5-year survival. The pooled 5-year survival rate of patients with breast cancer in Africa was 40.38% (95% CI 33.92 to 46.83%). Reduced survival was strongly associated with tumour characteristics, including tumour stage >2 (HR 3.06, 95% CI 2.02 to 4.09), negative oestrogen receptor status (HR 2.52, 95% CI 1.89 to 3.15), tumour size >5 cm (HR 1.62, 95% CI 1.48 to 1.76), positive nodal status (HR 1.64, 95% CI 1.58 to 1.70) and higher histological grade (HR 1.26, 95% CI 1.22 to 1.29). Treatment-related factors such as single-agent chemotherapy (HR 1.78, 95% CI 1.04 to 2.53) and patient-related factors, including comorbidities (HR 1.45, 95% CI 1.40 to 1.50) and illiteracy (HR 6.54, 95% CI 4.39 to 8.69), were also associated with reduced survival. Conclusion: This study reveals a critically low 5-year survival rate of 40.4% for breast cancer in Africa. Poor survival is linked to advanced tumour features, suboptimal treatment and patient-related factors, with comorbidities and illiteracy being the strongest patient-related factors. These results highlight the urgent need for integrated strategies focused on early diagnosis, public education, equitable access to multimodal therapies and systematic management of comorbidities across the continent. PROSPERO registration number: CRD420261387399.

  • Open Access

    Development and Validation of a Clinical Prognostic Risk Score for Stillbirth in Ethiopia: A Cohort Study Using PMA Data

    by Chalie Mulugeta, Tadele Emagneneh, Belay Susu, Aynalem Yetwale, Adem Yesuf, Nigus Bililign Yimer, Abebaw Alamrew

    Background: Stillbirth remain a major public health concern, particularly in low‐resource settings. Early identification of women at risk can significantly improve neonatal outcomes. This study aimed to Development and Validation of a Clinical Prognostic Risk Score for Stillbirth in Ethiopia: A Cohort Study Using PMA Data. Methods: A predictive model was developed using Performance Monitoring for Action (PMA) data from women. The data were exported to R version 4.4.3 for cleaning and analysis. Fifteen candidate predictors were initially considered and selected using Least Absolute Shrinkage and Selection Operator (LASSO) logistic regression with 10‐fold cross‐validation. Model performance was evaluated in terms of discrimination (area under the curve [AUC]), calibration, Brier score, and the Spiegelhalter test. Clinical usefulness was assessed using decision curve analysis (DCA). Internal validation was performed using bootstrap resampling. Finally, a simplified risk score and nomogram were developed to facilitate clinical application. Results: Predictors retained in the final model included prolonged labor, membrane rupture before 9 months, membrane rupture > 24 h during delivery, and partner encouragement for ANC. The model demonstrated excellent discrimination (AUC = 0.905) and calibration (optimism‐corrected slope = 1.005; Brier score = 0.0072; Spiegelhalter p = 1.00). The simplified risk score (range 0–10) showed strong discrimination, with high scores strongly associated with stillbirth (LR 159.7 for scores 9–10). Using a cutoff ≥ 2, the model achieved 83% sensitivity, 93% specificity, 15% PPV, and 100% NPV. Conclusion: The four‐factor prediction model, along with its simplified risk score and nomogram, accurately identifies pregnancies at high risk of stillbirth in Ethiopian women. By providing individualized risk estimates, the tool can support clinical decision‐making and help prioritize interventions for those most at risk. External validation is needed before it can be widely applied in practice.

  • Open Access

    Factors associated with meconium stained amniotic fluid and birth outcomes among mothers at Woldia Comprehensive Specialized Hospital

    by Tadele Emagneneh, Aynalem Yetwale, Abebaw Alamrew, Alemnew Wendimu, Gemeda Kusse, Rahmet Adem, Amanuel Tebebal Nega, Abebe Kassa Geto, Chalie Mulugeta

  • Open Access

    Determinants of Recovery From Obstetric Fistula in Ethiopia: A Systematic Review and Meta‐Analysis

    by Chalie Mulugeta, Tadele Emagneneh, Assefa Sisay, Getinet Kumie, Esuyawkal Mislu, Henok Kumsa, Adem Yesuf, Abebaw Alamrew

    Aim: This study aimed to assess the prevalence of recovery from obstetric fistula and identify factors associated with recovery amongst women in Ethiopia. Design: A systematic review and meta‐analysis of retrospective cohort studies were conducted. Methods: A comprehensive search was performed in PubMed, Google Scholar, EMBASE, Cochrane Library and Hinari using relevant keywords and Boolean operators. In addition, grey literature sources such as Google Scholar, institutional repositories and reports from international organisations. Data extraction was done using Microsoft Excel, and statistical analyses were conducted in Stata version 11. The methodological quality of the studies was assessed using the Newcastle–Ottawa Scale. Publication bias was evaluated with a funnel plot and Egger's test, and heterogeneity was measured using the I‐squared statistic. Results: Ten studies including 2382 participants from four regions of Ethiopia, were analysed. The pooled prevalence of recovery from obstetric fistula was 80.42% (95% CI: 75.74–85.10). Factors significantly associated with recovery included: maternal height ≤ 150 cm (AHR: 1.30; 95% CI: 1.14–1.47; I 2 = 83.5%), antenatal care attendance (AHR: 1.30; 95% CI: 1.08–1.52; I 2 = 96.8%), institutional delivery (AHR: 1.40; 95% CI: 1.12–1.70; I 2 = 97.3%), duration of incontinence < 3 months (AHR: 1.41; 95% CI: 1.11–1.71), intact urethra (AHR: 2.27; 95% CI: 1.39–3.14; I 2 = 99.3%), vaginal delivery (AHR: 1.69; 95% CI: 1.10–2.28; I 2 = 99.1%) and fistula width ≤ 2 cm (AHR: 1.43; 95% CI: 1.05–1.81; I 2 = 97%). No Patient or Public Contribution: This study was based on previously published studies, and no direct patient or public involvement was included. Conclusion: Recovery from obstetric fistula in Ethiopia remains suboptimal. Factors significantly associated with better recovery outcomes included maternal height, antenatal care attendance, institutional delivery, mode of delivery, duration of incontinence ≤ 3 months, intact urethra and fistula width ≤ 2 cm. Targeted interventions focusing on these factors—such as increasing antenatal care uptake, promoting institutional deliveries and ensuring early management of incontinence—are essential to improve recovery outcomes for affected women. Trial Registration: PROSPERO: CRD420261422331

  • Open Access

    Global, regional and national burden of maternal haemorrhage (2000–2021) and projections to 2050 in 204 countries and territories

    by Mulat Ayele, Bereket Duko, Tenaw Tiruye, Paul R Ward, Lillian Mwanri, Gavin Pereira, Tegene Atamenta Kitaw, Biruk Beletew Abate, Eyob Shitie Lake, Abebaw Alamrew, et al.

    Objective To estimate the global, regional and national burden of maternal haemorrhage (2000–2021) and its 2050 projections in 204 countries and territories. Design This study systematic analysis of the burden of maternal haemorrhage sourced data from the Global Burden of Disease (GBD) 2021 study. We estimated the incidence, mortality, disability-adjusted life years (DALYs), years lived with disability (YLDs) and years of life lost (YLLs) due to maternal haemorrhage. Changes in the burden from 2000 to 2021 were computed using AAPC. To detect statistically notable changes in the trends of maternal haemorrhage metrics between 2000 and 2021, Joinpoint regression analysis using the Joinpoint Regression Programme was conducted. We also projected mortality rates, YLDs and YLLs through to 2050 using maps and trends generated by the GBD Foresight visualisation tool. Results Globally, the incidence of maternal haemorrhage among women aged 15–49 years declined from 881.98 per 100 000 reproductive aged women (95% uncertainty interval (UI) 687.01 to –1150.23) in 2000 to 714.00 (95% UI 556.97 o t908.54) in 2021, with an average annual percentage change (AAPC) of –0.91 (–1.37 to –0.49). Similar downward trends were observed for maternal deaths, DALYs, YLDs and YLLs attributable to maternal haemorrhage, with AAPCs of –3.78 (–4.39 to –3.18), –4.68 (–4.83 to –4.55), –1.21 (–1.54 to –0.89) and –4.80 (–5.10 to –4.52), respectively. Sub-Saharan Africa, particularly Western Sub-Saharan Africa, recorded the highest burden in 2021, which is almost 300 times higher than in Western Europe. Elevated rates of mortality, DALYs and YLDs were also evident in Sierra Leone, Chad, Niger, Mali, Nigeria, Burkina Faso, Central African Republic, Somalia and South Sudan in 2021 and projections for 2050. However, the high-income Asia Pacific region had the lowest incidence, DALYs and YLDs at 151.32 (109.63–203.68), 2.21 (1.72–2.86) and 0.87 (0.46–1.38) per 1 00 000 women, respectively. Australasia recorded the lowest maternal death count and YLLs attributed to maternal haemorrhage at 0.69 (0.50–0.90) and 0.56 (0.41–0.74) per 1 00 000 women, respectively. Conclusion While the global burden of maternal haemorrhage has declined over time, significant regional and national inequities persist. Even though the 2050 projections show improvement in the burden of maternal haemorrhage, there is also regional and national variation in the rate of decrease in maternal haemorrhage burden. Targeted, context-specific interventions are urgently needed to reduce maternal haemorrhage-related mortality and morbidity.

  • Open Access

    Development and validation of a risk prediction model for preterm premature rupture of membranes: a cross-sectional study at North Wollo Zone governmental hospitals, Northern Ethiopia

    by Tadele Emagneneh, Chalie Mulugeta, Nigus Bililgn Yimer, Betelhem Ejigu, Abebaw Alamrew, Delelegn Tsegaye, Amanuel Tebabal Nega, Aynalem Yetwale

    Objectives: To develop and validate a risk prediction model for preterm premature rupture of membranes (PPROM) to enable early identification of at-risk women and support clinical decision-making in North Wollo Zone, Ethiopia. Design: A hospital-based retrospective cross-sectional study. Setting: Six public hospitals in the North Wollo Zone, Northern Ethiopia. Participants: A total of 1098 pregnant women were included in the study using systematic random sampling. Primary outcome measures: Occurrence of PPROM. Methods: Data were collected between 20 November 2023 and 20 March 2024, using structured interviews and medical record reviews. A risk prediction model was developed using Least Absolute Shrinkage and Selection Operator and logistic regression. Model performance was assessed through area under the curve (AUC), calibration plots and the Hosmer-Lemeshow test. Internal validation was conducted via bootstrap resampling. A simplified risk score was created to categorise women into high-risk and low-risk groups, and its clinical utility was evaluated using decision curve analysis. Results: Among the 1098 participants (100% response rate), the mean age was 21.54 years (IQR: 18–26), with 57.2% aged 20–34 years. The prevalence of PPROM was 10.75% (95% CI 9.01% to 12.77%). Seven significant predictors were identified: maternal age <20 years, urinary tract infection, anaemia, history of PROM, pregnancy-induced hypertension, short birth interval and polyhydramnios. The model demonstrated good discrimination (AUC=0.873; bias-corrected AUC=0.87). A simplified risk score (range 3–13) using a cut-off of ≥6.5 classified women into low-risk and high-risk groups, with PPROM incidence rates of 4.76% and 38.7%, respectively. Decision curve analysis showed good clinical utility, and a nomogram was developed for individualised risk assessment. Conclusions: PPROM remains a significant obstetric complication in the study area. The validated risk prediction model showed moderate to good performance and can be used to support early screening and risk-based management in antenatal care (ANC). Integrating the tool into routine ANC services, along with health education and management of modifiable risk factors, may help reduce PPROM-related adverse outcomes. Further external validation is recommended.


  • Open Access

    Structural equation analysis on the inter-relationships between optimal antenatal care, health facility delivery and early postnatal care among women in Ethiopia: EDHS 2016

    by Sefineh Fenta Feleke, Natnael Amare Tesfa, Abebe Kassa Geto, Tesfaye Engdaw Habtie, Seada Seid Ahmed, Getachew Ashagrie, Mulat Awoke Kassa, Berihun Mulu Yayeh, Tadele Emagneneh

    Objective This study employs structural equation modelling to explore the inter-relationships among optimal antenatal care (ANC), health facility delivery and early postnatal care (EPNC) in Ethiopia. By identifying both direct and indirect influencing factors, the study offers valuable insights to support integrated maternal health strategies and guide informed decision-making by policymakers and women alike. Design The secondary analysis of the Ethiopian Demographic and Health Survey 2016 was performed to investigate inter-relationships between optimal ANC, health facility delivery and postnatal care (PNC) among women in Ethiopia. Data were analysed with R software V.4.3.2. The study used binary logistic regression to examine differences in optimal ANC, health facility delivery and EPNC, focusing on variables with a p value of 0.1 or less. Selected variables were incorporated into a generalised structural equation model (GSEM) using the LAVAAN package to explore both direct and indirect effects. The GSEM method assessed the impact of exogenous variables on endogenous variables, all binary, using a logistic link and binomial family. Missing data were handled with the multiple imputation by chained equations package, and sampling weights were applied to ensure national and regional representativeness. Setting and participant The source population comprised all women of reproductive age (15–49 years) who gave birth in the 5 years preceding the survey. From 16 650 interviewed households (98% response rate), we identified 7590 eligible women with recent births. Finally, we included 2415 women who had attended four or more ANC visits. Result Media exposure significantly boosts the likelihood of using ANC (OR=1.8, 95% CI (1.04 to 3.23), p=0.04), health facility delivery (OR=1.7, 95% CI (1.23 to 2.45), p=0.05) and PNC (OR=2.0, 95% CI (1.6 to 4.01), p=0.01). Urban residence and secondary education also enhance ANC (OR=1.2, 95% CI (1.01 to 2.88), p=0.022; OR=1.3, 95% CI (1.20 to 3.01), p=0.018), health facility delivery (OR=1.1, 95% CI (1.01 to 3.24), p=0.035; OR=1.5, 95% CI (1.22 to 3.45), p=0.03) and PNC (OR=1.6, 95% CI (1.01 to 4.32), p=0.03). ANC directly affects health facility delivery (OR=1.4, 95% CI (1.28 to 3.09), p=0.01) and PNC (OR=1.6, 95% CI (1.01 to 3.80), p=0.03). Additionally, women aged 20–34 years and those from male-headed households positively impact health facility delivery (OR=1.5, 95% CI (1.20 to 4.80), p=0.01; OR=1.3, 95% CI (1.07 to 3.45), p=0.014) and PNC (OR=1.4, 95% CI (1.10 to 2.90), p=0.01; OR=1.2, 95% CI (1.07 to 3.08), p=0.025). Conclusions Optimal ANC is vital for encouraging health facility delivery and EPNC. To enhance maternal and neonatal health, policies should integrate these services. Key predictors include being aged 20–34, having secondary and higher education, media exposure, male-headed households and living in urban areas. Improving education and media exposure can boost maternal healthcare service use.